Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.

Bill KLJ, Seligson ND, Hays JL, Awasthi A, Demoret B, Stets CW, Duggan MC, Bupathi M, Brock GN, Millis SZ, Shakya R, Timmers CD, Wakely PE Jr, Pollock RE, Chen JL.

Oncologist. 2019 Jul;24(7):989-996. doi: 10.1634/theoncologist.2019-0047. Epub 2019 Apr 24.


Multidisciplinary sarcoma care.

Pollock RE, Payne JE, Rogers AD, Smith SM, Iwenofu OH, Valerio IL, Zomerlei TA, Howard JH, Dornbos D 3rd, Galgano MA, Goulart C, Mendel E, Miller ED, Xu-Welliver M, Martin DD, Haglund KE, Bupathi M, Chen JL, Yeager ND.

Curr Probl Surg. 2018 Dec;55(12):517-580. doi: 10.1067/j.cpsurg.2018.10.006. Epub 2018 Nov 9. No abstract available.


Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series.

Bupathi M, Hays JL, Chen JL.

PLoS One. 2017 Nov 15;12(11):e0188116. doi: 10.1371/journal.pone.0188116. eCollection 2017.


Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer.

Ahn DH, Reardon J, Ahn CW, Bupathi M, Mikhail S, Wu CS, Bekaii-Saab T.

Int J Cancer. 2018 Apr 15;142(8):1671-1675. doi: 10.1002/ijc.31144. Epub 2017 Nov 17.


Therapeutic options for intrahepatic cholangiocarcinoma.

Bupathi M, Ahn DH, Bekaii-Saab T.

Hepatobiliary Surg Nutr. 2017 Apr;6(2):91-100. doi: 10.21037/hbsn.2016.12.12. Review.


Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectives.

Bupathi M, Ahn DH, Bekaii-Saab T.

Gastrointest Cancer. 2016;6:21-30. doi: 10.2147/GICTT.S97740. Epub 2016 Jun 30.


Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others.

Bupathi M, Wu C.

J Gastrointest Oncol. 2016 Oct;7(5):713-720. Review.


Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience.

Bupathi M, Hajjar J, Bean S, Fu S, Hong D, Karp D, Stephen B, Hess K, Meric-Bernstam F, Naing A.

Invest New Drugs. 2017 Feb;35(1):59-67. doi: 10.1007/s10637-016-0395-y. Epub 2016 Sep 29.


Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience.

Bupathi M, Ahn DH, Wu C, Ciombor KK, Stephens JA, Reardon J, Goldstein DA, Bekaii-Saab T.

Med Oncol. 2016 Apr;33(4):37. doi: 10.1007/s12032-016-0753-9. Epub 2016 Mar 19.


Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients.

Subbiah V, Bupathi M, Kato S, Livingston A, Slopis J, Anderson PM, Hong DS.

Oncoscience. 2015 Jul 8;2(7):646-58. eCollection 2015.


Hepatocellular carcinoma: Where there is unmet need.

Bupathi M, Kaseb A, Meric-Bernstam F, Naing A.

Mol Oncol. 2015 Oct;9(8):1501-9. doi: 10.1016/j.molonc.2015.06.005. Epub 2015 Jun 25. Review.


Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives.

Bupathi M, Kaseb A, Janku F.

Onco Targets Ther. 2014 Oct 20;7:1927-32. doi: 10.2147/OTT.S46457. eCollection 2014. Review.


SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.

Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F, McMahon J, Makishima H, Szpurka H, Jankowska A, Jerez A, Sekeres MA, Saunthararajah Y, Advani AS, Copelan E, Koseki H, Isono K, Padgett RA, Osman S, Koide K, O'Keefe C, Maciejewski JP, Tiu RV.

Blood. 2012 Oct 18;120(16):3173-86. doi: 10.1182/blood-2012-05-430876. Epub 2012 Jul 23.


Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.

Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A, Przychodzen B, Bupathi M, Guinta K, Afable MG, Sekeres MA, Padgett RA, Tiu RV, Maciejewski JP.

Blood. 2012 Apr 5;119(14):3203-10. doi: 10.1182/blood-2011-12-399774. Epub 2012 Feb 9.


Acquired erythrocytosis upon treatment with infliximab for ankylosing spondylitis.

Antonelli M, Bupathi M, Janakiram M, Hergenroeder P, Khan MA.

J Rheumatol. 2011 Mar;38(3):581-3. doi: 10.3899/jrheum.101013. No abstract available.


Supplemental Content

Loading ...
Support Center